Back icon Back
NewLimit

NewLimit

Company

NewLimit raises $130 million Series B led by Kleiner Perkins alongside NFDG, Khosla Ventures, Human Capital and others
NewLimit is developing medicines to extend human healthspan through epigenetic reprogramming
We founded NewLimit to develop medicines that add healthy years to each human life. Initially, we thought it would take many years to show progress

https://blog.newlimit.com/p/newlimit-raises-130-million-series

Date

May 6, 2025

Category

biotech

Lead investor

Country Icon Kleiner Perkins

Stage

Series B

Size

$130M

Explore similar Investments to NewLimit

Company
Size
Date
Lead Investor
Press
Twill

Twill

Company
$1.4M
Dec 17, 2024
Investor Bloomberg Beta
Source
Pythagora

Pythagora

Company
$4M
May 14, 2024
Investor Zeno Partners
Source
Gamma

Gamma

Company
$12M
May 15, 2024
Investor Accel
Source
Layer

Layer

Company
$6.6M
Jul 9, 2025
Investor Emergence Capital
Source
Tailor

Tailor

Company
$22M
Jun 30, 2025
Investor ANRI
Source
Plenful

Plenful

Company
$50M
Apr 30, 2025
Investor Notable Capital
Source
LiveKit

LiveKit

Company
$22.5M
Jun 4, 2024
Investor Altimeter Capital
Source
Durin

Durin

Company
$3.4M
Apr 23, 2025
Investor 8090 Industries
Source
Cogent

Cogent

Company
$11M
Jul 15, 2025
Investor Greylock
Source
Gumloop

Gumloop

Company
$17M
Jan 10, 2025
Investor Nexus Venture Partners
Source
Fundamental Labs

Fundamental Labs

Company
$33M
Aug 1, 2025
Investor Prosus Ventures
Source
Keychain

Keychain

Company
$15M
Nov 19, 2024
Investor BoxGroup
Source

Startups, venture funds
& everything in between.

Explore verified companies, top VCs, and practical guides built to help you raise, invest, and grow faster.
Made by Omnius. For builders, by builders.
Venture Funds Startups Investments Events Programs Case Studies Interviews & Lectures Reports & Publications